We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New System Detects Multiple Biomolecular Interactions

By Biotechdaily staff writers
Posted on 06 Feb 2003
A new tool for pharmaceutical developers is a system that incorporates laser technologies, advanced electronics, microfluidics, and proprietary biochips and software to detect and analyze specific biomolecular interactions.

Called VeriScan, the MEMS (micro-electronic mechanical systems)-based biosensor is capable of detecting interactions with parts-per-trillion sensitivity. More...
Detection is based on recent discoveries that adsorption of proteins creates molecular scale stresses. These stresses can be detected using miniature, micro-machined, mass-produced silicon structure known as microcantilevers. The Veri-Scan 300 monitors the movement of microcantilevers, which are smaller than the width of human hair, by focusing tiny laser beams on the free ends of the microcantilevers.

The VeriScan was developed by Protiveris, Inc. (Rockville, MD, USA; www.protiveris.com). The company employs an array of microcantilevers with customizable surfaces that measure distinct label-free biomolecular interactions, including protein-protein, protein-DNA, and receptor-ligand interactions in its consumable products and disposable biochips. Protiveris is working with customers to develop proteomic-based research including receptor-ligand, immunologic, and metabolism studies.

"The beauty of our technology is that it offers real-time simultaneous detection of multiple protein assays with high sensitivity and selectivity without the use of any external labels,” said Sebastian Kossek, chief science officer, Protiveris.




Related Links:
Protiveris

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.